Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 1513 - 1520 of 12016 results
FCC and NSF Workshop on AI for Communications Networks and Consumers — AI: The Washington Report
July 20, 2023| Article| Viewpoint
New York and Connecticut Increase Regulation Over Hospital and Health System Facility Fees
July 20, 2023| Blog| Viewpoint
Tax Court Confirms that Profits Interest Safe Harbor Should Apply to Tiered Partnership Structure
July 18, 2023| Alert| Viewpoint
Attention Lobbyists and Registrants: A New Code of Conduct Has Come Into Effect in Canada
July 18, 2023| Blog| Viewpoint
Those Aren’t Doritos: FTC and FDA Send Warning Letters to Companies Marketing Delta-8 Infused Munchies
July 18, 2023| Blog| Viewpoint
Will a Half-Victory for Ripple Labs Create a Wave of Good News for Digital Asset Exchanges?
July 14, 2023| Blog| Viewpoint
NYC Releases Automated Employment Decision Tools FAQs Addressing Certain Lingering Questions
July 13, 2023| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|